Ignite Creation Date:
2024-05-06 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02751931
Status:
COMPLETED
Last Update Posted:
2022-10-20
First Post:
2016-04-22
Brief Title:
Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
Sponsor:
Astellas Pharma Europe BV
Organization:
Astellas Pharma Inc